EP Device Implant v2.3 Education-Post Procedure Events Discharge Medications – Lead Location, 9265; Discharge Medication Code, 10200

Post Procedure Events Discharge Medications – Lead Location, 9265; Discharge Medication Code, 10200

Video Transcription

Video Summary

This video transcript discusses lead dislodgement in post-procedure events and discharge medications. The new lead locations will capture dislodgements in different areas. Medication coding has been reordered and angiotensin receptor naprilicin inhibitor, renin inhibitor, and selective sinus node LF channel inhibitor options have been added. The angiotensin receptor naprilicin inhibitor (ARNI) is a combination drug that reduces blood pressure. Renin inhibitors block the activity of renin and vasodilation. Selective sinus node inhibitors target the sinoatrial pacemaker and help the left ventricle contract more efficiently.

Keywords

patient evaluation

non-invasive testing

ischemia assessment

cardiac CTA

Coronary Artery Disease

lead dislodgement

discharge medications

angiotensin receptor naprilicin inhibitor

renin inhibitor

selective sinus node LF channel inhibitor